Dialysis patients may benefit from common supplements, study finds
NCT ID NCT07303088
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether taking L-carnitine or Coenzyme Q10 supplements could lower oxidative stress (a type of cell damage) in adults with end-stage kidney disease who are on regular hemodialysis. Fifty-two participants took one of the supplements or a placebo for 12 weeks, followed by a 12-week washout period. Researchers measured blood markers of oxidative stress before, after treatment, and after the washout to see if the supplements helped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Social security fund polyclinic
Sfax, Sfax Ville, 3080, Tunisia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can video games and electric pulses ease dialysis Patients' shoulder pain?
- Dialysis danger: a new model aims to predict sudden blood pressure crashes
- A helping hand for dialysis: can coaching reduce the emotional toll?
- A simple blood pressure cuff trick could shield the heart in kidney disease
- Could cutting dialysis sessions in half improve life for seniors?
- Teaching dialysis patients to take control: can a Four-Week Nurse-Led program improve diet and Self-Care?